What are the mechanisms that favor relatively mild upper respiratory infections compared to pneumonia, alveolar injury, or multisystem disease in SARS-CoV-2?
Current evidence indicates that factors such as co-infections with other viruses and balanced immune responses might favor milder SARS-CoV-2 infections, but direct evidence remains limited. Further research is needed to identify specific mechanisms underlying differential clinical presentations.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24371644
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00